These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1570856)

  • 1. SK tray: a device to encourage streptokinase use.
    Saltiel E; Chun CO; Shane RR
    Am J Hosp Pharm; 1992 Jan; 49(1):136-7. PubMed ID: 1570856
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.
    Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute myocardial infarction: thrombolytic efficacy of 500.000 UI of streptokinase combined with heparin].
    Aninat M; Col JJ; Rankin J; Jacquet L; Anwar A; Etienne J
    Rev Med Chil; 1990 Aug; 118(8):862-7. PubMed ID: 2152229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytic therapy in myocardial infarction. Great regional differences].
    Beermann B
    Lakartidningen; 1994 Mar; 91(11):1059-61. PubMed ID: 8139332
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of fibrinolytics in the treatment of acute myocardial infarction in Denmark. A questionnaire study].
    Nielsen JD; Stoltenberg M; Siemsen M; Juul A; Pedersen F; Madsen JK
    Ugeskr Laeger; 1990 Aug; 152(33):2368-70. PubMed ID: 2120830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction.
    Taylor R; Fatovich D; Hitchcock T; Morrison C; Curtis L
    Clin Sci (Lond); 2001 Jun; 100(6):601-7. PubMed ID: 11352774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of thrombolytic therapy in acute myocardial infarction.
    Dutta AL; Mandal M
    J Indian Med Assoc; 1991 Nov; 89(11):322-4. PubMed ID: 1787323
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary thrombolysis and previous SK therapy.
    Massel D
    Can J Cardiol; 1993; 9(6):518-20. PubMed ID: 8221347
    [No Abstract]   [Full Text] [Related]  

  • 9. Streptokinase in acute myocardial infarction: a multicentric study in an Indian setting. Streptokinase Multicentric Trial Group.
    Indian Heart J; 1993; 45(3):189-94. PubMed ID: 8314272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of thrombolytic therapy on mortality of inpatients at adult intensive care units at the Municipal Hospital].
    Tarkieltaub E
    Arq Bras Cardiol; 1995 Apr; 64(4):345-6. PubMed ID: 7495394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombolysis (Consensus about post-myocardial infarction treatment)].
    Arq Bras Cardiol; 1995 Mar; 64(3):271-80. PubMed ID: 7487519
    [No Abstract]   [Full Text] [Related]  

  • 12. Multicenter clinical trial using an accelerated streptokinase regimen in patients with acute myocardial infarction.
    Xu C; Zhang T
    Chin Med J (Engl); 2000 Aug; 113(8):733-6. PubMed ID: 11776059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of intravenous streptokinase therapy in acute myocardial infarction.
    Suresh V
    J Assoc Physicians India; 1994 Apr; 42(4):346. PubMed ID: 7860572
    [No Abstract]   [Full Text] [Related]  

  • 14. [Streptokinase in myocardial infarction].
    Piegas LS; Cano SJ; Souza JE
    Arq Bras Cardiol; 1991 Mar; 56(3):259-60. PubMed ID: 1888297
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of thrombolysis during menstruation.
    Nandini S; Ravindranath ; Pais N
    J Assoc Physicians India; 1994 Jan; 42(1):84. PubMed ID: 7836264
    [No Abstract]   [Full Text] [Related]  

  • 16. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction.
    Balduini CL; Noris P; Bertolino G; Previtali M
    Thromb Haemost; 1993 May; 69(5):522-3. PubMed ID: 8322276
    [No Abstract]   [Full Text] [Related]  

  • 18. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous streptokinase in the treatment of acute myocardial infarct].
    Lupínek Z; Janousek S; Lupínková Z; Meluzín J; Novák M; Soucek M; Rysavý F
    Vnitr Lek; 1991 Jan; 37(1):21-8. PubMed ID: 2058094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptokinase immunogenicity in thrombolytic therapy for acute myocardial infarction.
    Rosenschein U; Lenz R; Radnay J; Ben Tovim T; Rozenszajn LA
    Isr J Med Sci; 1991 Oct; 27(10):541-5. PubMed ID: 1955306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.